To fully determine the machinery that controls docetaxel resistance in PC cells, further in-depth studies on which molecule in AR signaling is actually regulated by UC.63+ need to be elucidated; this could be a potential game changer in the treatment of PC. The gene discussed is AR; the disease is pachyonychia congenita.